Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT01694810 Completed - Acne Vulgaris Clinical Trials

Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers

Start date: September 2012
Phase: Phase 1
Study type: Interventional

The study will assess safety and tolerability of different doses of topical gel containing a new chemical entity, NVN1000, and the vehicle (gel without drug) applied to the face of healthy volunteers with high counts of Propionibacterium acnes. The test product will be applied once daily for 4 weeks. Exploratory measures include whether the topical product decreases the amount of a bacteria associated with acne (P. acnes).

NCT ID: NCT01694433 Completed - Acne Vulgaris Clinical Trials

"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"

Start date: February 2013
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to study the effects of topical Vitamin D cream (Calcipotriene, also known as Dovonex) on acne. The information gained from this study may lead to new treatments for acne. In this study, Calcipotriene will be compared with a placebo, a cream that looks like Calcipotriene, but contains no active ingredients.

NCT ID: NCT01689935 Completed - Acne Vulgaris Clinical Trials

Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT)

i-PDT
Start date: November 2009
Phase: Phase 1
Study type: Interventional

This research study aims to compare different methods for helping difficult to treat or scarring (cystic) acne, ALA-PDT and i-PDT. There is an investigational procedure called photodynamic therapy (ALA-PDT) that has been reported to be very efficient for acne treatment since 2000. Photodynamic therapy (PDT) uses a drug called ALA (aminolevulinic acid), which is marketed as Levulan®. Levulan® is applied directly to facial/back acne. This is the way that it is usually applied. Levulan® is left on the skin for three hours so the skin can absorb it. Next, the skin where the Levulan® was applied is exposed to a red light for activation. The sebaceous glands get obstructed and inflamed causing acne. ALA gets down under your skin through the skin pores to where the glands are. PDT destroys the glands reducing the acne lesion. Levulan® is absorbed by normal skin surrounding the oil glands. Therefore, this procedure also has some side effects. Some of the side effects include pain, burning sensation during the procedure, and redness, tenderness, and swelling after the procedure. At Massachusetts General Hospital's Wellman Center for Photomedicine, the investigators developed another procedure called inhibitory-PDT (i-PDT) that is similar to ALA-PDT. i-PDT is aimed at reducing the side-effects of ALA- PDT. The difference between these two procedures is that i-PDT uses a light source that will prevent Levulan® accumulation in the normal skin surface. The investigators would like to find out if Levulan® will be placed only inside the sebaceous glands.

NCT ID: NCT01688531 Completed - Acne Clinical Trials

A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

Start date: August 2012
Phase: Phase 1
Study type: Interventional

Exploratory, international, multi-centre, randomized, investigator blinded study in acne

NCT ID: NCT01687556 Completed - Acne Vulgaris Clinical Trials

EGCG Improves Acne by Modulating Molecular Targets

EGCG
Start date: July 2005
Phase: N/A
Study type: Interventional

Epigallocatechin-3-gallate (EGCG) may improve acne vulgaris - major polyphenolic constituent in green tea - known as potent anti-carcinogenic, anti-inflammatory, anti-proliferative, and antimicrobial activities - lipid-lowering and antiandrogenic properties was reported - EGCG can improve acne vulgaris via one of the above mentioned actions.

NCT ID: NCT01682200 Completed - Acne Vulgaris Clinical Trials

Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne

Start date: October 2009
Phase: Phase 1
Study type: Interventional

This study was conducted to determine the effects and side effects of ProOxy facial spray in the treatment of acne.

NCT ID: NCT01677221 Completed - Acne Vulgaris Clinical Trials

Effects of Acleara Needle Insert on Acne

Start date: July 2012
Phase: N/A
Study type: Interventional

This prospective, open-label study will be conducted in 15 healthy subjects per clinical site ages 14 or older who meet the inclusion/exclusion criteria. Each subject may have up to 5 lesions treated on the face, chest or back with the Acleara insert. Subjects will receive up to 3 follow up visits and evaluated for improvement in acne lesions and monitored for any adverse events.

NCT ID: NCT01645345 Completed - Wrinkles Clinical Trials

Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

Start date: July 2012
Phase: N/A
Study type: Interventional

To assess the safety and efficacy of the Pixel RF (fractional radio frequency) module in the treatment of acne scars and wrinkles.

NCT ID: NCT01631474 Completed - Acne Vulgaris Clinical Trials

A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris

Start date: June 2012
Phase: Phase 2
Study type: Interventional

CB-03-01 is being developed for the topical treatment of acne vulgaris, an androgen-dependent skin disorder. The purpose of this study is to compare the safety and efficacy of multiple concentrations of CB-03-01 to vehicle in the treatment of acne vulgaris.

NCT ID: NCT01629797 Completed - Acne Vulgaris Clinical Trials

Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne

Start date: May 2012
Phase: N/A
Study type: Interventional

Acne vulgaris is a chronic inflammatory disorder of the skin in the pilosebaceous unit of the hair follicle, associated with oil production. It is found across skin types and is present in 85% of adolescents, representing a large affected population. Because of the universal nature of the disease, 36.3% of acne patients come from backgrounds other than Caucasian. The purpose of this study is to examine patient knowledge about acne in different populations and to assess the effectiveness of a teaching intervention on acne knowledge. The investigators aim is to better understand and subsequently reduce any potential health disparities within the minority populations. This project will evaluate differences in acne knowledge between different ethnic groups, and the efficacy of an educational intervention. Subjects will first complete a survey evaluating their knowledge of acne and how acne affects them psychosocially before an educational intervention. Immediately following the intervention, the patient's knowledge of acne will be evaluated again. Finally, two months after the intervention, a phone call will be made evaluating their retention of the education materials and their quality of life related to psychosocial effects of acne. Investigating this educational intervention and any current disparities in acne education and understanding will better allow us to educate and treat acne patients in the future.